Deccan Health Care Ltd.
Snapshot View

28.50 +0.35 ▲1.2%

27 July 2021, 04:00:00 P.M.
Volume: 8,400

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.decanhealthcare.co.in
Financial Indicators
Market Cap 44.23 Cr.
Earnings per share (EPS) 0.25 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 113.42 Trailing Twelve Months Ending 2021-03
Industry PE 35.25 Trailing Twelve Months Ending 2021-03
Book Value / Share 48.51 Trailing Twelve Months Ending 2021-03
Price to Book Value 0.58 Calculated using Price: 28.15
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 1.57 Cr. 15,713,430 Shares
FaceValue 10
Company Profile

The Company was originally incorporated as Deccan Health Care Limited at Hyderabad, Andhra Pradesh as a Public Limited Company under the provision of Companies Act, 1956 vide Certificate of Incorporation dated June 14, 1996 issued by the Registrar of Companies, Andhra Pradesh, Hyderabad. Subsequently, the Company was converted into a private limited company and the name of the Company was changed to Deccan Health Care Private Limited vide a Fresh Certificate of Incorporation dated June 12, 2009, issued by the Assistant Registrar of Companies, Andhra Pradesh. Further, the Company was converted into a public limited company pursuant to special resolution passed by the members in Extraordinary General Meeting held on August 12, 2017 and the name of the Company  was  changed  to  Deccan Health Care Limited vide a Fresh Certificate of Incorporation dated August 31, 2017, issued  by the Registrar of Companies, Andhra Pradesh, Hyderabad.

Business area of the Company:

The Company is engaged in developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products. In the present competitive era of medicines and food supplements, it aims to distinguish its identity by focusing on ways to bridge the nutrition gap which is a recognised cause of many diseases. It mainly develops and market differentiated healthcare products specializing in nutraceutical and cosmeceutical products, which it commercialize through different revenue channels that takes the products solutions to the consumers which includes network of distributors, marketing agents, direct to consumers and e-commerce channel for its domestic sales. The Company offers more than 1500 products. These products are used for various purposes such as hair care, skin care, heart care, immunity building etc. The Company offers a long-chain omerga-3 fatty acid, joint health nutrients, diacerein, antioxidants, immune enhancing components, skin ageing products, instant energy drinks, and calcium supplements; and a formula for males. The Company supplies their products in various forms such as tablets, capsules, gel, liquids, ointments, powder, pastes, etc.

Major Events and Milestones:

  • 1996: Incorporation of the company as a Public Limited Company
  • 1996: Certificate of Commencement of business
  • 2009: Conversion of Company into Private Limited Company
  • 2010: Set up of the Manufacturing Facility of the Company at Rudrapur, Uttarakhand
  • 2017: Conversion of Company into Public Limited Company
  • 2018: Entered into an MOU with Uttar Pradesh government to establish technology park
  • 2018: Enrolled as member of Federation of Indian Direct Selling Industries

Key Awards, Certifications, Accreditations and Recognitions:

  • 2015: Certified as an ISO-9001:2008 Company
  • 2018: Certified as an ISO-9001:2015 Company from ICM Certification Private Limited
  • 2018: Certified as an ISO-9001:2015 Company from EQFS Certification
  • 2018: Certified as ISO 9001:2015 Company from German Cert. Co. Ltd.
  • 2018: Received certificate of Compliance of WHO-GMP from NFI Certification Limited
  • 2018: Received certificate of Compliance of Good Laboratory Practice (GLP) systems from NFI Certification Limited
  • 2018: Received Certificate of Excellence from ASSOCHAM for Best Fastest Growing Online Nutrition Store
  • 2018: Received Certificate of Excellence from ASSOCHAM for Best Wellness Brand
  • 2018: Awarded Skoch Order of Merit for qualifying amongst Top -100 SMEs in India
  • 2018: Received Global Sustainability Leadership Awards

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+1.24%
1 Week
+5.56%
1 Month
-6.86%
3 Month
-10.80%
6 Month
+9.83%
1 Year
-25.00%
2 Year
-65.16%
5 Year
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -59.17 -38.15 -47.88 -17.65 41.69 48.74 39.11 25.78 14.17
Return on Capital Employed (%) -28.74 -14.86 -14.16 1.30 22.50 35.84 32.92 25.04 14.22
Return on Assets (%) -28.82 -16.02 -14.86 -4.31 14.33 21.67 22.25 18.89 11.47

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 26 19 14 12 17 22 46 66 76
Non Curr. Liab. 11 11 13 16 17 13 11 3 3
Curr. Liab. 5 10 6 4 4 15 14 14 14
Minority Int.
Equity & Liab. 42 40 33 32 38 50 70 83 93
Non Curr. Assets 22 21 19 18 17 19 32 26 27
Curr. Assets 20 20 14 14 21 31 39 57 66
Misc. Exp. not W/O 0 0 0 0
Total Assets 42 40 33 32 38 50 70 83 93

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 8 9 7 9 13 29 38 44 42
Other Income 1 0 0 0 4 0 2 0 0
Total Income 9 9 7 9 17 29 40 44 42
Total Expenditure -18 -13 -10 -7 -9 -17 -24 -27 -31
PBIDT -9 -4 -3 2 8 13 16 17 12
Interest -2 -1 -2 -2 -1 -2 -2 -1 0
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0
Exceptional Items 0 0
PAT -12 -7 -5 -1 5 10 13 14 10

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. -3 1 0 -1 2 13 3 1
Cash Fr. Inv. 0 0 0 -1 -13 -12 -2
Cash Fr. Finan. 3 -2 0 1 -1 0 13 0
Net Change 0 0 0 0 0 0 4 -1
Cash & Cash Eqvt 0 0 0 0 0 0 4 3

Shareholding Pattern View Details

7 Qtrs 2017-03 (%) 2018-03 (%) 2019-03 (%) 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%)
Promoter 77.79 74.51 51.39 51.30 45.61 35.94 35.70
Public 22.21 25.49 48.61 48.70 54.39 64.06 64.30
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Wed, 21 Jul 2021
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Pursuant to compliance of Regulation 74(5) of the SEBI (Depositaries and Participants) Regulation 20l8 Compliance Certificate for non-applicability for the quarter ended 30th June 2021
Thu, 15 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- Sheena Jain
Designation :- Company Secretary and Compliance Officer
Wed, 14 Jul 2021
Announcement under Regulation 30 (LODR)-Meeting Updates
Deccan Health Care Limited FY 21 Results supplementary information

Technical Scans View Details

Mon, 26 Jul 2021
Stock Underperforming Benchmark Index in both 1 Week and 3 Month Stock Underperforming Benchmark Index in both 1 Week and 3 Month
Stock Underperforming Sectoral Index in both 1 Week and 3 Month Stock Underperforming Sectoral Index in both 1 Week and 3 Month
Strongly Underperforming Benchmark index Strongly Underperforming Benchmark index
Strongly Underperforming Sectoral index Strongly Underperforming Sectoral index
Both SRS And ARS Below Zero Both SRS And ARS Below Zero

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 168,769.22 688.00 -2.2%
Divi's Laboratories Ltd. 130,349.05 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. 90,021.63 4,844.35 -10.4%
Cipla Ltd. 76,675.40 913.20 -3.9%
Cadila Healthcare Ltd. 61,992.73 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. 58,965.37 4,078.80 -0.5%
Aurobindo Pharma Ltd. 55,837.02 905.70 -5.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 58.12 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2021-03 65.69 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 46.13 4,844.35 -10.4%
Cipla Ltd. Consolidated 2021-03 31.88 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 29.06 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 392.16 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2021-03 10.47 905.70 -5.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.63 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2021-03 14.02 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 5.14 4,844.35 -10.4%
Cipla Ltd. Consolidated 2021-03 4.18 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 4.77 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.83 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.55 905.70 -5.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,844.35 -10.4%
Cipla Ltd. Consolidated 2020-03 0.18 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 905.70 -5.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,844.35 -10.4%
Cipla Ltd. Consolidated 2020-03 10.09 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 905.70 -5.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,844.35 -10.4%
Cipla Ltd. Consolidated 2020-03 12.53 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 905.70 -5.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,844.35 -10.4%
Cipla Ltd. Consolidated 2020-03 17,131.99 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 905.70 -5.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,844.35 -10.4%
Cipla Ltd. Consolidated 2020-03 1,546.98 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 905.70 -5.0%